thiazolyl blue has been researched along with Arsenic Encephalopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YY; Chi, LL; Chiang, MC; Huang, RN; Kao, YH; Kuo, TC | 1 |
| Hara, S; Nishimoto, M; Sakaue, M | 1 |
2 other study(ies) available for thiazolyl blue and Arsenic Encephalopathy
| Article | Year |
|---|---|
The down-regulation of galectin-1 expression is a specific biomarker of arsenic toxicity.
Topics: 3T3 Cells; Animals; Antimony; Arsenic; Arsenic Poisoning; Biomarkers; Blotting, Western; Cadmium; Cell Cycle; Down-Regulation; Flow Cytometry; Galectin 1; Humans; KB Cells; Mice; Nickel; RNA Interference; Spectrophotometry, Atomic; Tetrazolium Salts; Thiazoles; Transfection | 2011 |
Short-interfering RNA-mediated silencing of thioredoxin reductase 1 alters the sensitivity of HeLa cells toward cadmium.
Topics: Arsenic Poisoning; Blotting, Northern; Cadmium Poisoning; Cell Death; Gene Silencing; HeLa Cells; Humans; Hydrogen Peroxide; Mercury Poisoning; Oxidants; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Thioredoxin Reductase 1; Thioredoxin-Disulfide Reductase; Transfection | 2006 |